Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.3 Bylaws of the Registrant As Currently In Effect
- 4.2 Amended and Restated Investors' Rights Agreement Dated February 7, 2005
- 10.1 Form of Indemnification Agreement
- 10.2 1997 Stock Plan, As Amended
- 10.3 2005 Equity Incentive Plan
- 10.5 Physician Plus Agreement Dated August 15, 2004
- 10.6 Distribution Agreement Dated June 30, 2004
- 10.7 Amended and Restated Distribution Agreement Dated March 1, 2005
- 10.8 Inr PST Supplier Agreement Dated April 2, 2004
- 10.9 Manufacture and Supply Agreement Dated March 7, 2005
- 10.10 Professional Service Agreement Dated October 29, 2003
- 10.11 Supply and License Agreement Dated March 5, 1999
- 10.12 Loan and Security Agreement No. 3821 Dated March 5, 2004
- 10.13 Settlement Agreement and Mutual Release Dated July 16,2004
- 10.14 Consulting Agreement Dated May 17, 2002
- 10.15 Non-exclusive Sales Representative and Services Agreement Dated Nov. 12, 2002
- 10.16 Distribution Agreement Dated April 1, 2003
- 10.17 Employment Agreement Dated June 3, 2002
- 23.1 Consent of Pricewaterhousecoopers LLP
Hemosense similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of our report dated March 30, 2005 relating to the financial statements and financial statement schedule of HemoSense, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 31, 2005